Cargando…

Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition

We evaluated costs for respiratory syncytial virus (RSV) medical attention in children aged <24 months using MarketScan® Medicaid Multi-State claims database 2015–2019. Average cost was highest for RSV hospitalization with intensive care unit (ICU) admission ($23 514–24 835), followed by no ICU a...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoonyoung, Finelli, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687602/
https://www.ncbi.nlm.nih.gov/pubmed/37850646
http://dx.doi.org/10.1093/jpids/piad086
_version_ 1785152012313165824
author Choi, Yoonyoung
Finelli, Lynn
author_facet Choi, Yoonyoung
Finelli, Lynn
author_sort Choi, Yoonyoung
collection PubMed
description We evaluated costs for respiratory syncytial virus (RSV) medical attention in children aged <24 months using MarketScan® Medicaid Multi-State claims database 2015–2019. Average cost was highest for RSV hospitalization with intensive care unit (ICU) admission ($23 514–24 835), followed by no ICU admission ($8039–8990), ED visits ($463–482), and outpatient visits ($145–151). Cost was higher for those with comorbidities.
format Online
Article
Text
id pubmed-10687602
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106876022023-12-01 Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition Choi, Yoonyoung Finelli, Lynn J Pediatric Infect Dis Soc Brief Reports We evaluated costs for respiratory syncytial virus (RSV) medical attention in children aged <24 months using MarketScan® Medicaid Multi-State claims database 2015–2019. Average cost was highest for RSV hospitalization with intensive care unit (ICU) admission ($23 514–24 835), followed by no ICU admission ($8039–8990), ED visits ($463–482), and outpatient visits ($145–151). Cost was higher for those with comorbidities. Oxford University Press 2023-10-18 /pmc/articles/PMC10687602/ /pubmed/37850646 http://dx.doi.org/10.1093/jpids/piad086 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Choi, Yoonyoung
Finelli, Lynn
Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition
title Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition
title_full Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition
title_fullStr Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition
title_full_unstemmed Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition
title_short Cost of Medically Attended RSV Among Medicaid Beneficiaries ≤2 Years of Age by Underlying Risk Condition
title_sort cost of medically attended rsv among medicaid beneficiaries ≤2 years of age by underlying risk condition
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687602/
https://www.ncbi.nlm.nih.gov/pubmed/37850646
http://dx.doi.org/10.1093/jpids/piad086
work_keys_str_mv AT choiyoonyoung costofmedicallyattendedrsvamongmedicaidbeneficiaries2yearsofagebyunderlyingriskcondition
AT finellilynn costofmedicallyattendedrsvamongmedicaidbeneficiaries2yearsofagebyunderlyingriskcondition